Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol
Calgary, Alberta--(Newsfile Corp. - October 15, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...
Clinical Trial
AccessHope Launches New Service to Help More Cancer Patients Enroll in Clinical Trials
Expands support and access by matching eligible patients to trials and guiding them through enrollment DUARTE, Calif., Oct. 15, 2025 /PRNewswire/...
TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research
With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top...
Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology
RADNOR, Pa. and PHILADELPHIA, Oct. 15, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to...
NanoViricides Dual Track Clinical Strategy Explained by a Research Report – Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute Respiratory Infections of All Viruses
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst...
Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros’ clinical-stage MASP-3 inhibitor zaltenibart (OMS906)
Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk’s Rare Disease portfolioOmeros is...
MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery
PRECISE study to generate pivotal clinical data for the Symani® Surgical System in free tissue transfer and lymphatic surgical repairJACKSONVILLE,...
Akari Therapeutics Announces $2.5 Million Registered Direct Offering
BOSTON and LONDON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) (the “Company”), an oncology biotechnology company...
Aignostics Launches AI-Powered Application for Tumor Microenvironment Profiling
Atlas H&E-TME delivers robust analyses at single-cell resolution in hours BERLIN and NEW YORK, Oct. 15, 2025 /PRNewswire/ -- Following...
Luminopia Recognized on Fast Company’s Next Big Things in Tech List
The annual list honors groundbreaking advancements redefining the way we work and live CAMBRIDGE, Mass., Oct. 14, 2025 /PRNewswire/ --...
Carolina Molecular Selected as Certified Service Provider for CS Genetics’ Single-Cell Sequencing Platform
Collaboration expands access to scalable, cost-efficient single-cell RNA sequencing for translational and clinical research MORRISVILLE, N.C. and SAN DIEGO, Oct....
OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care
BELLEVUE, Wash., Oct. 14, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH) today announced that it has executed a definitive agreement...
Sibel Health Secures Additional Series C Extension Funding to $39 million from Key Strategic Investors and Announces New Board of Director Appointments
CHICAGO, Oct. 14, 2025 /PRNewswire/ -- Sibel Health, an award-winning digital health company, today announced the close of a Series...
From Biotech to Grid Tech, Entero Therapeutics Enters a $2.5 Billion Market Expected to Quadruple by 2033 (NASDAQ:ENTO)
BOCA RATON, FL / ACCESS Newswire / October 14, 2025 / Entero Therapeutics (NASDAQ:ENTO) has reinvented itself in a way...
Red Light Holland Secures Second United States Controlled Substances Import Permit for the Company’s Psilocybin Through FDA-Compliant, DEA-Registered Partner Irvine Labs
Red Light Holland granted Second DEA Import Permit through Irvine Labs for expanded psilocybin research programThis United States Controlled Substances...
Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
LOS ANGELES, CA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the...
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...
LB Pharmaceuticals Appoints James Rawls, Pharm.D., as Senior Vice President of Regulatory Affairs
NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced...
CLn Skin Care Appoints Dr. Amir Moradi to Medical Advisory Board
Acclaimed Facial Plastic Surgeon and Educator Joins CLn Skin Care DALLAS, TEXAS / ACCESS Newswire / October 14, 2025 /...
Flare Therapeutics to Present FX-909 Phase 1A Data in Oral Presentation at Upcoming AACR-NCI-EORTC International Conference
CAMBRIDGE, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to...